Buspirone
DrugBuspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.
Other names: Omeprazole
NCT Number: NCT03444831
This study is a double-blinded Randomised clinical trial aim to compare buspirone plus omeprazole with placebo plus omeprazole.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Buspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.
Other names: Omeprazole
Buspirone placebo QID after meal plus 20mg omeprazole before breakfast.
Other names: omeprazole
Time frame: 4 weeks taking buspirone plus omeprasole or taking placebo plus omeprasloe
Global symptom measured through a checklist of dyspepsia symptoms at first visit and four weeks after
Isfahan University of Medical Sciences
Other
Buspirone Plus Omeprazole for Functional Dyspepsia: A Randomised Placebo Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05810168
Digestive System Diseases, Dyspepsia
Sheffield, South Yorkshire, United Kingdom
View Trial DetailsNCT05004012
Digestive System Diseases, Dyspepsia
Los Angeles, California, United States
View Trial DetailsNCT06760897
Dysbiosis, Dyspepsia
Guangzhou, Guangdong, China
View Trial DetailsNCT06150638
Colonic Diseases, Colonic Diseases, Functional
Barcelona, Spain
View Trial Details